A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
X Chi, R Yan, J Zhang, G Zhang, Y Zhang, M Hao… - Science, 2020 - science.org
Developing therapeutics against severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding …
CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding …
[HTML][HTML] A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
X Chi, R Yan, J Zhang, G Zhang, Y Zhang… - Science (New York …, 2020 - ncbi.nlm.nih.gov
Developing therapeutics against severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding …
CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding …
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
X Chi, R Yan, J Zhang, G Zhang, Y Zhang, M Hao… - Science, 2020 - ui.adsabs.harvard.edu
Developing therapeutics against severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding …
CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding …
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
X Chi, R Yan, J Zhang, G Zhang… - … (New York, NY), 2020 - pubmed.ncbi.nlm.nih.gov
Developing therapeutics against severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding …
CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding …
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
X Chi, R Yan, J Zhang, G Zhang, Y Zhang, M Hao… - Science, 2020 - cir.nii.ac.jp
抄録< jats: title> Hitting SARS-CoV-2 in a new spot</jats: title>< jats: p> A key target for
therapeutic antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
therapeutic antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
X Chi, R Yan, J Zhang, G Zhang, Y Zhang, M Hao… - paper.sciencenet.cn
Abstract Developing therapeutics against SARS-CoV-2 could be guided by the distribution
of epitopes, not only on the receptor binding domain (RBD) of the Spike (S) protein, but also …
of epitopes, not only on the receptor binding domain (RBD) of the Spike (S) protein, but also …
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
X Chi, R Yan, J Zhang, G Zhang, Y Zhang… - Science (New York …, 2020 - europepmc.org
Developing therapeutics against severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding …
CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding …
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
X Chi, R Yan, J Zhang, G Zhang, Y Zhang, M Hao… - 2020 - cabidigitallibrary.org
Developing therapeutics against severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding …
CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding …
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
X Chi, R Yan, J Zhang, G Zhang, Y Zhang… - Science (New York …, 2020 - europepmc.org
Developing therapeutics against severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding …
CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding …